Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ObsEva SA (OBSV : NSDQ)
 
 • Company Description   
ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.

Number of Employees: 51

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.74 Daily Weekly Monthly
20 Day Moving Average: 566,878 shares
Shares Outstanding: 77.97 (millions)
Market Capitalization: $135.67 (millions)
Beta: 0.67
52 Week High: $3.58
52 Week Low: $1.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 23.40% 38.98%
12 Week 31.82% 44.91%
Year To Date -12.56% 2.54%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Chemin des Aulx 12 Plan-les-Ouates
-
Geneva,V8 1228
CHE
ph: 41-22-552-3840
fax: -
ir@obseva.ch http://www.obseva.com
 
 • General Corporate Information   
Officers
Brian O'Callaghan - Chief Executive Officer and Director
Frank Verwiel - Chairperson of the Board of Directors
Will Brown - Chief Financial Officer
Clive Bertram - Chief Commercial Officer
Ernest Loumaye - Director

Peer Information
ObsEva SA (CORR.)
ObsEva SA (RSPI)
ObsEva SA (CGXP)
ObsEva SA (BGEN)
ObsEva SA (GTBP)
ObsEva SA (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: H5861P103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 77.97
Most Recent Split Date: (:1)
Beta: 0.67
Market Capitalization: $135.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.28 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.14 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.85
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 51.72%
vs. Previous Quarter: 46.15%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -137.37
12/31/21 - -139.32
09/30/21 - -158.43
ROA
03/31/22 - -54.10
12/31/21 - -60.96
09/30/21 - -63.28
Current Ratio
03/31/22 - 3.09
12/31/21 - 2.70
09/30/21 - 3.84
Quick Ratio
03/31/22 - -
12/31/21 - 2.70
09/30/21 - 3.84
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -2,232.01
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 0.36
12/31/21 - 0.41
09/30/21 - 0.57
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 1.18
12/31/21 - 0.80
09/30/21 - 0.58
Debt-to-Capital
03/31/22 - 54.23
12/31/21 - 44.31
09/30/21 - 36.71
 

Powered by Zacks Investment Research ©